Perceived unmet needs for health care among Parkinson's Society of New Zealand members with Parkinson's disease

Parkinsonism and Related Disorders

Volumn 14, Issue 6, 2008, Pages 495-500

  Buetow, Stephen ^a   Giddings, Lynne S ^b   Williams, Lisa ^b   Nayar, Shoba ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

Author keywords

Consumer participation; Health services needs and demand; Health services research; Needs assessment; Parkinson's disease

Indexed keywords

ARTICLE; CONTROLLED STUDY; FEMALE; GENERAL PRACTITIONER; HEALTH CARE; HEALTH CARE ACCESS; HEALTH SERVICE; HEALTH SERVICES RESEARCH; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MEDICAL SPECIALIST; NEEDS ASSESSMENT; NEW ZEALAND; PARKINSON DISEASE; PATIENT ASSESSMENT; PRIORITY JOURNAL;

AGED; CROSS-SECTIONAL STUDIES; DELIVERY OF HEALTH CARE; FAMILY PRACTICE; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; ODDS RATIO; PARKINSON DISEASE; PHYSICIAN-PATIENT RELATIONS; SPECIALISM; TELEPHONE;

EID: 49649107512     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.11.011     Document Type: Article

References (37)

1. Miyasaki J., Martin W., Suchowersky O., Weiner W., and Lang A. Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the quality standards subcommittee of the American academy of neurology. Neurology 58 (2002) 11-17
2. Playfer J. Targeting Parkinson's disease - the case for early referral. Curr Med Res Opin 16 (2000) 43-45
3. Kale R., and Menken M. Who should look after people with Parkinson's disease?. BMJ 328 (2004) 63-64
4. Deane K., Jones D., Playford E., Ben-Shlomo Y., and Clarke C. Physiotherapy versus placebo or no intervention in Parkinson's disease. Cochrane Database Syst Rev 3 (2001)
5. Stallibrasse C., Sissons P., and Chalmers C. Randomized controlled trial of the Alexander technique for idiopathic Parkinson's disease. Clin Rehabil 16 (2002) 695-708
6. Ramig L.O., Fox C., and Sapir S. Parkinson's disease: speech and voice disorders and their treatment with the Lee Silverman voice treatment. Semin Speech Lang 25 (2004) 169-180
7. Farley B.G., and Koshland G.F. Training BIG to move faster: the application of the speed-amplitude relation as a rehabilitation strategy for people with Parkinson's disease. Exp Brain Res 167 (2005) 462-467
8. Nieuwboer A., Kwakkel G., Rochester L., Jones D., van Wegen E., Willems A.M., et al. Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial. J Neurol Neurosurg Psychiatry 78 (2007) 134-140
9. Abbott R.D., Ross G.W., White L.R., Sanderson W.T., Burchfiel C.M., Kashon M., et al. Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia aging study. J Neurol 250 Suppl. 3 (2003) III30-III39
10. Wielinski C., Erickson-Davis C., Wichmann R., Walde-Douglas M., and Parashos S. Falls and injuries resulting from falls among patients with Parkinson's disease and other Parkinsonian syndromes. Mov Disord 20 (2005) 410-415
11. Ritz B., Ascherio A., Checkoway H., Marder K.S., Nelson L.M., Rocca W.A., et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 64 (2007) 990-997
12. Fleming A., Cook K., Nelson N., and Lai E. Proxy reports in Parkinson's disease: caregiver and patient self-reports of quality of life and physical activity. Mov Disord 20 (2005) 1462-1468
13. Pechevis M., Clarke C., Vieregge P., Khoshnood B., Deschaseaux-Voinet C., Berdeaux G., et al. Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs: a prospective European study. Eur J Neurol 12 (2005) 956-963
14. Den Oudsten B., Van Heck G., and De Vries J. Quality of life and related concepts in Parkinson's disease: a systematic review. Mov Disord 22 (2007) 1528-1537
15. Pasetti C., Ferrario R., Fornara R., Picco D., Foglia C., and Galli J. Caregiving and Parkinson's disease. Neurol Sci 24 (2003) 203-204
16. Janca A. A report on the WHO working group on Parkinson's disease. Neuroepidemiology 18 (1999) 236-240
17. Findley L., and Baker M. Treating neurodegenerative diseases. What patients want is not what doctors focus on. BMJ 324 (2002) 1466-1467
18. Clifford T., and Finnerty J. The dental awareness and needs of a Parkinson's disease population. Gerodontology 12 12 (1995) 99-103
19. Sheriff J., and Chenoweth L. Challenges in conducting research to improve the health of people with Parkinson's disease and the well-being of their family carers. Int J Rehabil Res 26 (2003) 201-205
20. European Parkinson's Disease Association (1997).
21. Fayers P., and Sprangers M. Understanding self-rated health. Lancet 359 9302 (2002) 187-188
22. Arroll B., Khin N., and Kerse N. Screening for depression in primary care with two verbally asked questions: cross-sectional study. BMJ 327 (2003) 1144-1146
23. Hill J., McVay J., Walter-Ginzburg A., Mills C., Lewis J., Lewis B., et al. Validation of a brief screen for cognitive impairment (BSCI) administered by telephone for use in the medicare population. Dis Manag 8 (2005) 223-234
24. Van Den Eeden S.K., Tanner C.M., Bernstein A.L., Fross R.D., Leimpeter A., Bloch D.A., et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157 (2003) 1015-1022
25. Taylor K., Cook J., and Counsell C. Heterogeneity in male to female risk for Parkinson's disease. J Neurol Neurosurg Psychiatry 78 (2007) 905-906
26. Ashburn A., Stack E., Pickering R., and Ward C. A community-dwelling sample of people with Parkinson's disease: characteristics of fallers and non-fallers. Age Ageing 30 (2001) 47-52
27. Weibtraub D., Moberg P., Duda J., Kata I., and Stern M. Recognition and treatment of depression in Parkinson's disease. J Geriatr Psychiatry Neurol 16 (2003) 178-183
28. Schrag A. Quality of life and depression in Parkinson's disease. J Neurol Sci 248 (2006) 151-157
29. Veazey C., Aki S., Cook K., Lai E., and Kunik M. Prevalence and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci 17 (2005) 310-323
30. Shulman L., Taback R., Rabinstein A., and Weiner W. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 8 (2002) 193-197
31. Aarsland D., Brønnick K., Ehrt U., De Deyn P., Tekin S., Emre M., et al. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 78 (2007) 36-42
32. Ridsdale L. Community care for patients with idiopathic Parkinson's disease. Br J Gen Pract 394 (1995) 226-227
33. Mutch W., Dingwall-Fordyce I., and Downie A. Parkinson's disease in a Scottish city. BMJ 292 (1986) 534-536
34. Ben-Schlomo Y., and Sieradzan K. Idiopathic Parkinson's disease: epidemiology, diagnosis and management. Br J Gen Pract 45 (1995) 261-268
35. Schrag A., Ben-Schlomo Y., and Quinn N. Cross-sectional prevalence survey of idiopathic Parkinson's disease and Parkinsonism in London. BMJ 321 (2000) 21-22
36. Hurwitz B., Jarman B., Cook A., and Bajekal M. Scientific evaluation of community-based Parkinson's disease nurse specialists on patient outcomes and health care costs. J Eval Clin Pract 11 (2005) 97-110
37. National Collaborating Centre for Chronic Conditions. Parkinson's disease. National clinical guideline for diagnosis and management in primary and secondary care (2006), Royal College of Physicians, London